John Ware
12 works · 478 citations · h-index 5
Top works
- Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.
- A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
- Comparison of medical and surgical management of coronary artery disease: methodologic issues.
- Neurophysins as tumor markers for small cell carcinoma of the lung: A cancer and leukemia group B evaluations
- Bisantrene in non-small cell lung cancer: a phase II trial of the Cancer and Leukemia Group B.
- Clinical Evaluation of the Neurophysins as Tumor Markers in Small Cell Lung Cancer
- 382 Phase Ib study of oral dual-PI3K/mTOR inhibitor GDC-0980 in combination with capecitabine and mFOLFOX6 + bevacizumab in patients with advanced solid tumors and colorectal cancer
- Rupture of the Aorta within the Pericardium
- PD09-04: A Phase Ib, Open-Label, Dose-Escalation Study of the Safety and Pharmacology of the PI3-Kinase Inhibitor GDC-0941 in Combination with Paclitaxel and Bevacizumab in Patients with Locally Recurrent or Metastatic Breast Cancer.
- MP44-04 PREDICTING THE 10-YEAR RISK OF DEATH FROM OTHER CAUSES IN MEN WITH LOCALIZED PROSTATE CANCER USING PATIENT-REPORTED FACTORS: DEVELOPMENT OF A TOOL
- MP5-16 EXTERNAL VALIDATION OF 10-YEAR OTHER CAUSE MORTALITY RISK ESTIMATION TOOLS FOR MEN NEWLY DIAGNOSED WITH PROSTATE CANCER
- PD12-05 DEFINING THE EXTENT AND NATURE OF OVERTREATMENT OF PROSTATE CANCER IN OLDER MEN